United Pharm (033270)

Currency in KRW
20,700
-50(-0.24%)
Delayed Data·

033270 Financial Summary

Key Ratios

P/E Ratio16.7
Price/Book1.94
Debt / Equity13.85%
Return on Equity12.21%
Dividend Yield2.17%
EBITDA29.64B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2006
31/03
2007
31/03
2007
31/12
2008
31/12
2009
31/12
2010
31/12
2011
31/12
2012
31/12
2013
31/12
2014
31/12
* In Millions of KRW (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,260.90%
Dividend Yield
2.17%
Industry Median 0.93%
Annualised payout
450.00
Paid annually
5-Years Growth
-
Growth Streak

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 30,000
(+44.93% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
72.60B / --
EPS Revisions
Last 90 days

FAQ

What was United Pharm's net income for the latest quarter?

United Pharm's net income for the latest quarter was 4,941.84.

How did United Pharm's performance compare year-over-year in the latest quarter?

The company's revenue moved from 39,347.13 in the previous quarter to 39,953.12 in the latest quarter, and net income moved from 4,113.39 to 4,941.84 compared to the previous quarter.

What is United Pharm's net profit margin on a TTM basis?

United Pharm's trailing twelve months (TTM) net profit margin is 11.84%.

How does United Pharm's debt to equity ratio compare to industry standards?

United Pharm's total debt-to-equity ratio is 13.85%.

What is United Pharm's return on investment on a TTM basis?

United Pharm's trailing twelve months (TTM) return on investment (ROI) is 12.21%.

Did United Pharm gain or lose cash last quarter?

In the latest quarter, United Pharm's net change in cash was -6.15 million.

What were United Pharm's total assets and liabilities in the latest quarter?

As of the latest quarter, United Pharm reported total assets of 223,903.70 million and total liabilities of 29,402.78 million.

How has United Pharm's total revenue grown this year?

United Pharm's total revenue was 39,347.13 in the previous quarter and 39,953.12 in the latest quarter.

What was United Pharm's revenue per share for the latest quarter?

United Pharm's revenue per share for the latest quarter was 14,240.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.